PORT VILA,Vanuatu,March 17,2025-- Vantage Markets participated as a Titanium Sponsor at Money Expo Mexico 2025,held on February 26-27. The event,known as one of the most significant gatherings for tr
NEW YORK,March 18,2025-- After selling out in just two days,COSRX\'s highly anticipated The Ceramide Skin Barrier Moisturizer has become a sensation in the skincare world. Fans and skincare enthusiast
URUMQI,China,March 17,2025--On March 14,State GridXinjiang Information &TelecommunicationCompany,leveraging the integration of party building and business operations as a platform,organized a &quo
SINGAPORE,March 18,2025-- Singapore\'s tourism and retail industries are undergoing a transformation,with Chinese tourists increasingly relying on digital platforms like Meituan Dianping and Xiaohongs
BEIJING,March 18,2025-- Farmers are busy pollinating cherry blossoms in the cherry greenhouses ofQicun Town,Shizhong District in Zaozhuang City,east China\'s Shandong Province,paving the way for a bum
In two engaging discussions,HONOR sheds light on the envisioned future that the HONOR ALPHA PLAN will achieve
NEW YORK,Feb. 17,2025-- Lanvin Group (NYSE: LANV,the "Group"),a global luxury fashion group,todayopened registration for its 2024revenue results conference call. The Group will release its
The executive brings significant experience in critical finance roles at sizeable companies LONDON,Feb. 17,2025-- Boldyn Networks (Boldyn),one of the world\'s largest shared network infrastructure pr
XI\'AN,China,Feb. 14,2025-- 7th February,2025,The global leading authority and non-profit organization CDP released the 2024 scores for the Climate Change,Water Security,and Forests questionnaires. A
SHANGHAI,Feb. 14,2025-- Success in the fitness industry goes beyond high-end equipment and expert trainers. According toYR Fitness,effective gym layout design is a game-changer,boosting member satisfa
SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu